Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |